Table 3 Association of BRAF mutations with the number of metastatic sites in patients with stage IV melanoma
From: Clinical significance of BRAF mutations in metastatic melanoma
Number of Sites Per Patients | BRAF Status | P value* | |
|---|---|---|---|
| Â | Mutation N = 27 (%) | Wild Type N = 24 (%) | Â |
5 | 4 (14.8%) | 0 | p = 0.048 |
4 | 4 (14.8%) | 3 (12.5%) | Â |
3 | 6 (22.2%) | 5 (20.8%) | Â |
2 | 5 (18.5%) | 3 (12.5%) | Â |
1 | 8 (29.6%) | 13 (54.2%) | Â |